Current Opinion in Investigational Drugs | Most viewed articles in past year

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries jobs about my BioMed Central

Quick Search

	Current Opinion in Investigational Drugs
	BioMed Central
	PubMed Central
	PubMed

Jump to article


vol.	page no.

Current Opinion in Investigational Drugs

Most viewed

Current Opinion in Investigational Drugs: Most viewed articles in past year

[more info]

Figures given indicate the abstract, full text and PDF accesses on BioMed Central for each article, over the last year. All research articles are also available via the PubMed Central archive, so the total number of accesses to each article is significantly higher. Lists of most-viewed articles over the last 30 days and of all time most-viewed articles are also available

most viewed articles over the last year from all BioMed Central Journals

1. Accesses 350	Review DGAT inhibitors for obesity D Matsuda, H Tomoda Current Opinion in Investigational Drugs 2007, 8:836-841 (28September2007) [PDF] [PubMed] [Related articles]
2. Accesses 339	Review Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes CF Deacon Current Opinion in Investigational Drugs 2008, 9:402-413 (4April2008) [PDF] [PubMed] [Related articles]
3. Accesses 303	Review Sirtuins: Novel targets for metabolic disease PJ Elliott, M Jirousek Current Opinion in Investigational Drugs 2008, 9:371-378 (4April2008) [PDF] [PubMed] [Related articles]
4. Accesses 294	Review Biologicals in the treatment of psoriasis A Boker, AB Kimball, G Rolz-Cruz Current Opinion in Investigational Drugs 2007, 8:939-946 (2November2007) [PDF] [PubMed] [Related articles]
5. Accesses 275	Review Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis MK Hansen, TM Connolly Current Opinion in Investigational Drugs 2008, 9:247-255 (28February2008) [PDF] [PubMed] [Related articles]
6. Accesses 249	Review CNTO-1275, a mAb against IL-12/IL-23p40 for the potential treatment of inflammatory diseases BM Wittig Current Opinion in Investigational Drugs 2007, 8:947-954 (2November2007) [PDF] [PubMed] [Related articles]
7. Accesses 242	Review Sodium-glucose cotransporter inhibitors for diabetes M Isaji Current Opinion in Investigational Drugs 2007, 8:285-292 (28March2007) [PDF] [PubMed] [Related articles]
8. Accesses 236	Review Evolution of schizophrenia drugs: A focus on dopaminergic systems SS Nikam, AK Awasthi Current Opinion in Investigational Drugs 2008, 9:37-46 (7January2008) [PDF] [PubMed] [Related articles]
9. Accesses 224	Review ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases C Ding, J Xu, J Li Current Opinion in Investigational Drugs 2008, 9:515-522 (25April2008) [PDF] [PubMed] [Related articles]
10. Accesses 208	Review Selective nicotinic acetylcholine receptor agonists: Potential therapies for neuropsychiatric disorders with cognitive dysfunction SL Cincotta, MS Yorek, TM Moschak, SR Lewis, JS Rodefer Current Opinion in Investigational Drugs 2008, 9:47-56 (7January2008) [PDF] [PubMed] [Related articles]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us